Tag: Switzerland
Señales de éxito: la campaña de la Sociedad Suiza de EM gana el premio a la innovación
The ‘Innovation of the Year’ fundraising award was presented in recognition of the Swiss MS Society’s 2017 World MS Day event, ‘We send a signal’.
European Medicines Agency recommends market authorisation for ocrelizumab (Ocrevus) in EU
The EMA has recommended that ocrelizumab (Ocrevus), the first disease-modifying treatment for primary progressive MS (PPMS), be prescribed for adults with early primary progressive MS
Lo más destacado del Día Mundial de la EM
A flavour of how global MS organisations marked World MS Day 2017
Mejora de la calidad de vida para las personas con EM
Training programme led to significant improvements in manual dexterity